Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SODIUM, MONOBASIC, ANHYDROUS for Hypophosphataemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 6 adverse event reports in the FDA FAERS database where SODIUM, MONOBASIC, ANHYDROUS was used for Hypophosphataemia.

Most Reported Side Effects for SODIUM, MONOBASIC, ANHYDROUS

Side Effect Reports % Deaths Hosp.
Vomiting 21 28.8% 18 15
Abdominal distension 20 27.4% 20 14
Methaemoglobinaemia 20 27.4% 0 20
Stress 17 23.3% 17 11
Abdominal pain 16 21.9% 16 10
Appendicitis 16 21.9% 16 10
Appendicolith 16 21.9% 16 10
Ascites 16 21.9% 16 10
Hyponatraemia 16 21.9% 16 10
Cardiogenic shock 15 20.6% 15 9
Constipation 15 20.6% 15 9
General physical health deterioration 15 20.6% 15 9
Multiple organ dysfunction syndrome 15 20.6% 15 9
Nausea 15 20.6% 15 9
Off label use 15 20.6% 15 10

Other Indications for SODIUM, MONOBASIC, ANHYDROUS

Product used for unknown indication (27) Constipation (21)

Other Drugs Used for Hypophosphataemia

BUROSUMAB-TWZA (109) ASFOTASE ALFA (29) CALCITRIOL (19) CALCIUM, DIBASIC, ANHYDROUS\MAGNESIUM GLYCEROPHOSPHATE\PHOSPHORIC ACID\SODIUM, DIBASIC (17) ALPHA.-GLUCOSE-1-PHOSPHATE (8) PHOSPHORUS (8) SODIUM (8) SEVELAMER (7) SUCROFERRIC OXYHYDROXIDE (7) SODIUM, MONOBASIC (6)

Related Pages

SODIUM, MONOBASIC, ANHYDROUS Full Profile All Hypophosphataemia Drugs SODIUM, MONOBASIC, ANHYDROUS Demographics SODIUM, MONOBASIC, ANHYDROUS Timeline